<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">SUBHASITANONT, PANTIPA</style></author><author><style face="normal" font="default" size="100%">SRISOMSAP, CHANTRAGAN</style></author><author><style face="normal" font="default" size="100%">PUNYARIT, PHAIBUL</style></author><author><style face="normal" font="default" size="100%">SVASTI, JISNUSON</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Proteomic Studies of Galectin-3 Expression in Human Thyroid Diseases by Immunodetection</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Genomics - Proteomics</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2006-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">389-394</style></pages><volume><style face="normal" font="default" size="100%">3</style></volume><issue><style face="normal" font="default" size="100%">6</style></issue><abstract><style  face="normal" font="default" size="100%">Galectin-3 expression in thyroid diseases was studied by 1-DE immunoblotting. Expression was markedly elevated in thyroid papillary carcinoma, compared to follicular adenoma, follicular carcinoma or non-neoplastic diseases. Galectin-3 expression was also elevated in malignant cancers of bone, breast, colon, esophagus, larynx, lung and ovary. Four cases of thyroid papillary carcinoma with metastasis gave 2-3 bands on 1-DE immunoblotting. 2-DE immunoblotting of gelectin-3 showed 3 dark spots with MW/pI 32.9/8.29, 31.0/8.40 and 30.0/8.40 and 2 light spots.</style></abstract></record></records></xml>